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1. Oxidative Heck reaction on protein bound alkenes 
1.1 Preparation of protein bound alkenes 
1.1.1 General 
The 4-OT R61C gene was purchased from DNA2.0, Inc. (Menlo Park, CA). The technique for 
transformation was based on a method reported in literature.[1] For purification of the 4-OT 
enzyme pre-packed PD-10 Sephadex G-25 gelfiltration columns were used. The protein was 
analyzed using precasted 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) gels (NuPAGE® 10% Bis-Tris gel, Invitrogen™, Carlsbad, CA). As a ladder Fermentas 
PageRuler™ Prestained Protein Ladder was used. Gels were stained with the coomassie 
based gel stain InstantBlue™ (Expedeon Ltd, Harston, Cambridgeshire, UK). Protein 
concentrations of the unmodified enzyme were determined using the method of Waddell,[2] 
using the absorbance as measured on a V-660 spectrophotometer from Jasco (IJsselstein, 
The Netherlands). The Bradford assay was used to determine the concentration of the 
chemically modified enzyme[3] using Coomassie Protein Assay Reagent (950 mL) from 
Thermo Scientific from which the absorbance was measured on a SPECTROstar Omega – 
UV/Vis absorbance spectrophotometer microplate reader from BMG Labtech. Gel imaging 
was performed on a Chemi Genius2 Bio Imaging System. The EtBr/UV emission filter (550-
640nm) was used for fluorescence imaging of the gels.  
RAW264.7 Cells were purchased from American Type Culture Collection, Manassas, USA and 
Dulbecco’s Modified Eagle Medium (DMEM) from Life Technologies.  
The protein mass spectrometry was performed usinga Shimadzu LC system, consisting of a 
LC-20AD gradient pumps and a SIL-20AC autosampler. Chromatographic separation was 
achieved on an Alltima C18 column (2.1x150 mm, 5 μm, Grace Davison Discovery Sciences). 
The injection volume was 50 μL. Elution was performed by a linear gradient from 5% to 60% 
eluent B mixed with eluent A in 30 min, followed by an increase to 90% eluent B in 1 min, 
where it was kept 4 min, after which it returned to the starting conditions. Eluent A was 
99.5% H2O / 0.5% formic acid and eluent B was 95.5% acetonitrile/0.5% formic acid. The flow 
rate was 0.3 mL/min. The UV signal was recorded at 220 nm. The HPLC system was coupled 
to an API 3000 triple-quadrupole mass spectrometer (Applied Biosystems/MDS Sciex) via a 
TurboIonSpray source. The ionization was performed by electrospray in the positive ion 
mode. Data acquisition and processing was performed using the Analyst software version 
1.4.2 and 1.5 (Applied Biosystems/MDS Sciex). Multiply charged peak envelopes of proteins 
were deconvoluted in Analyst; all reported mass spectra show the reconstructed, uncharged 
peaks. Mass spectra were recorded in profile mode with 0.1 amu step size, and the mass 
accuracy of reconstructed protein masses is estimated at 100 ppm. 






1.1.3 Expression and purification 4-OT R61C 
The 4-OT R61C mutant enzyme was produced in E. coli BL21 (DE3) as a native protein 
without His-tag using the Pj Express 414 expression system. The purification was performed 
according to literature procedures.[4]  
4-OT R61C was stored in 0.5 mL cups as a 10 mg/ml solution (determined by Waddell 
method) in ammonium formate buffer (pH 8.0, 50 mM). An aliquot of this protein sample 
was directly analysed by ESI-MS. 
The cups containing the protein solution were snapfrozen in liquid nitrogen and kept in -
20oC.  
ESI-MS spectrum 4-OT R61C: mass expected= 6757, mass found= 13513 (dimer) 
 
 
Note: The mass of 13644 shows that, in a small extent, during the expression of the enzyme 
the amino acid methionine was not cleaved. The mass of 13671 corresponds to the 
formylated methionine.  
1.2 Preparation of the 4-OT conjugates 
1.2.1 Reduction of 4-OT R61C dimer and coupling with 1-(pent-4-en-1-yl)-1H-pyrrole-2,5-
dione (4-OT R61C-1) 
The protein solution was warmed to room temperature. A 130 μL aliquot (96 nmol) was 
added to a 1.5 mL cup along with sodium phosphate buffer (300 μL, pH 8.0, 50 mM). A stock 
solution of dithiothreitol (DTT) was prepared by dissolving DTT (3.1 mg, 0.02 mmol) in 
sodium phosphate buffer (320 μL, pH 8.0, 50 mM). In order to reduce the disulfide, 30 μL of 
S5 
 
the DTT stock solution was added to the protein solution and the mixture was shaken at 
room temperature for 10 min. A stock solution of 1-(pent-4-en-1-yl)-1H-pyrrole-2,5-dione (1) 
was prepared by dissolving 1 (34 mg, 0.21 mmol) in CH3CN (334 μL). The final concentration 
of the stock was 0.63 M. 30 μL of the stock solution of 1 was added to the protein solution 
and the mixture was shaken at room temperature for 10 min. The protein was purified by 
using PD-10 size exclusion. The column was washed 3 times with deionized water and 3 
times with ammonium formate buffer (pH 7.0, 50 mM). The sample was loaded onto the 
column and elution was conducted with the same buffer. The fractions containing 4-OT were 
identified by polyacrylamide gel electrophoresis and the concentration of the protein was 
determined using the Bradford assay and a solution of known concentration of reduced 4-OT 
R61C in DTT as a reference.  
A 0.65 mg/ml protein solution was prepared. An aliquot of this protein solution was directly 
analyzed by ESI-MS. Mass spectrometry revealed a protein peak with a mass corresponding 
to the mass of 4-OT R61C-1.  
ESI-MS spectrum: mass expected 6922, mass found 6923 (7054: modified enzyme with 
methionine, 7081: modified enzyme with formylated methionine). 
 
1.2.2 Reduction of 4-OT R61C dimer and coupling with (Z)-1-(hex-4-en-1-yl)-1H-pyrrole-2,5-
dione (4-OT R61C-2) 
 
The reduction of the dimer was done according to the procedure described for 4-OT R61C-1. 
A stock solution of (Z)-1-(hex-4-en-1-yl)-1H-pyrrole-2,5-dione (2) was prepared by dissolving 
2 (38 mg, 0.21 mmol) in CH3CN (334 μL). The final concentration of the stock was 0.63 M. 30 
μL of the stock solution of 2 was added to the protein solution and the mixture was shaken 
at room temperature for 10 min. The purification of the protein and the concentration 
assessment were done as described for 4-OT R61C-1. A solution containing 0.65 mg/mL was 
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prepared in ammonium formate buffer (pH 7.0, 50 mM). An aliquot of this protein sample 
was directly analyzed by ESI-MS. Mass spectrometry revealed a protein peak with mass 
corresponding to the mass of 4-OT R61C-2.  
ESI-MS spectrum: mass expected 6936, mass found 6938 (7069: modified enzyme with 
methionine, 7096: modified enzyme with formylated methionine) 
 
 
1.2.3 Reduction of 4-OT R61C dimer and coupling with (E)-1-(hex-4-en-1-yl)-1H-pyrrole-2,5-
dione (4-OT R61C-3) 
 
The reduction of the dimer was done according to the procedure described for 4-OT R61C-
1. A stock solution of (E)-1-(hex-4-en-1-yl)-1H-pyrrole-2,5-dione (3) was prepared by 
dissolving 3 (38 mg, 0.21 mmol) in CH3CN (334 μl). 30 μL of this solution was added to the 
reduced 4-OT R61C-1 and the reaction mixture was shaken at room temperature for 10 
min. The purification of the protein and the concentration assessment were done as 
described for 4-OT R61C-1. A solution containing 0.65 mg/mL was prepared in ammonium 
formate buffer (pH 7.0, 50 mM). An aliquot of this protein sample was directly analyzed by 
ESI-MS. Mass spectrometry revealed a protein peak with a mass corresponding to the mass 
of 4-OT R61C-3.  
ESI-MS spectrum: mass expected 6936, mass found 6937 (7068: modified enzyme with 




1.2.4 Reduction of 4-OT dimer and coupling with N-ethylmaleimide (4-OT R61C-4) 
 
The reduction of the dimer was done according to the procedure described for 4-OT R61C-1. 
A stock solution of N-ethylmaleimide was prepared by dissolving the N-ethylmaleimide (31 
mg, 0.25 mmol) in CH3CN (0.4 ml). 30 μL of this solution was added to the reduced 4-OT 
R61C-1 and the reaction mixture was shaken at room temperature for 10 min. The 
purification of the protein and the concentration assessment were done as described for 4-
OT R61C-1. A solution containing 0.65 mg/mL was prepared in ammonium formate buffer 
(pH 7.0, 50 mM). An aliquot of this protein sample was directly analyzed by ESI-MS. Mass 
spectrometry revealed a protein peak with mass corresponding to the mass of 4-OT R61C-4.  
ESI-MS spectrum: mass expected 6882, mass found 6883 (7014: modified enzyme with 




1.3 Oxidative Heck reaction for bioorthogonal protein ligation 
1.3.1 Preparation of stock solutions 
Palladium (II)-BIAN catalyst stock solution 
BIAN (4.3 mg, 11 μmol) and Pd(OAc)2 (1.8 mg, 8 μmol) were dissolved in DMF (1 mL) in a 10 
mL double neck round bottom flask equipped with a magnetic stirring bar and a septum. The 
flask was equipped with an oxygen balloon on the side arm. Oxygen was flushed through the 
flask and the mixture was left stirring for 30 min at room temperature. The final 
concentration in Pd was 8 mM and in BIAN 11 mM. 
Note: Mass spectrometric analysis proved to be difficult, presumably, due to the fact that 
palladium (II) binds to aminoacids such as histidine.[5] In order to resolve this problem, EDTA 
was used to chelate palladium after the completion of the reaction. 
EDTA stock solution (1.0 M, pH 7.0) 
Ethylenediaminetetraacetic acid disodium salt dihydrate (18.6 g, 50 mmol) was dissolved in 
deionized H2O (50 mL) and the pH was set at 7.0 using a concentrated solution of NaOH. 
1.3.2 Coupling of phenylboronic acid to protein bound terminal alkene 4-OT R61C-1 
 
A stock solution was prepared by dissolving phenylboronic acid (4.0 mg, 33 μmol) in 
Na2HPO4
. 2H2O buffer (825 μL, pH 7.0, 0.5 M), after shaking at room temperature for 10 min. 
The final concentration in phenylboronic acid was 40 mM. 
50 equiv. catalyst/300 equiv. phenylboronic acid 
210 μL of the solution of protein 4-OT R61C-1 (20 nmol), 150 μL of the phenylboronic acid 
stock solution (6.0 μmol) and 125 μL of the catalyst stock solution (1.0 μmol in Pd, 1.4 μmol 
in BIAN) were added in a 10 mL double neck round bottom flask, equipped with a magnetic 
stirring bar and a septum. The reaction mixture was left stirring at room temperature under 
oxygen atmosphere. After 24 h, it was transferred into a 2 mL cup and 500 μL of the EDTA 
stock solution was added. The solution was left rotating for 3 h at room temperature. A 
microextraction was then performed using n-heptane (3x500 μL). Each time the sample was 
homogenized by vortexing carefully and the organic phase was removed. LC-MS analysis 
showed full conversion of the protein 4-OT R61C-1 to protein 4-OT R61C-5. 




20 equiv. catalyst/100 equiv. phenylboronic acid 
210 μL of the solution of protein 4-OT R61C-1 (20 nmol), 50 μL of the phenylboronic acid 
stock solution (2.0 μmol) and 50 μL of the catalyst stock solution (400 nmol in Pd, 550 nmol 
in BIAN) were added in a 10 mL double neck round bottom flask, equipped with a magnetic 
stirring bar and a septum. The reaction mixture was left stirring at room temperature under 
oxygen atmosphere. After 24 h, it was transferred into a 2 mL cup and 200 μL of the EDTA 
stock solution was added. The solution was left rotating for 3 h at room temperature. A 
microextraction was then performed using n-heptane (3x500 μL). Each time the sample was 
homogenized by vortexing carefully and the organic phase was removed. LC-MS analysis 
showed full conversion of the protein 4-OT R61C-1 to protein 4-OT R61C-5. 







10 equiv. catalyst/50 equiv. phenylboronic acid 
210 μL of the solution of protein 4-OT R61C-1 (20 nmol), 25 μL of the phenylboronic acid 
stock solution (1.0 μmol) and 25 μL of the catalyst stock solution (200 nmol in Pd, 275 nmol 
in BIAN) were added in a 10 mL double neck round bottom flask, equipped with a magnetic 
stirring bar and a septum. The reaction mixture was left stirring at room temperature under 
oxygen atmosphere. After 24 h, it was transferred into a 2 mL cup and 100 μL of the EDTA 
stock solution was added. The solution was left rotating for 3 h at room temperature. A 
microextraction was then performed using n-heptane (3x500 μL). Each time the sample was 
homogenized by vortexing carefully and the organic phase was removed. LC-MS analysis 
showed a protein mass corresponding to the mass of product 4-OT R61C-5 but also a peak 
with a mass corresponding to protein 4-OT R61C-1. 
ESI-MS spectrum: mass expected 6999, mass found 7000  
 
1.3.3 Coupling of 4-methoxyphenylboronic acid to protein bound terminal alkene 4-OT 
R61C-1 
 
A stock solution was prepared by dissolving 4-methoxyphenylboronic acid (4.9 mg, 32 μmol) 
in Na2HPO4
.2H2O buffer (400 μL, pH 7.0, 0.5 M) and DMF (400 μL). The final concentration in 
4-methoxyphenylboronic acid was 40 mM. 
210 μL of the solution of protein 4-OT R61C-1 (20 nmol), 50 μL of the 4-
methoxyphenylboronic acid stock solution (2.0 μmol) and 50 μL of the catalyst stock solution 
(400 nmol in Pd, 550 nmol in BIAN) were added in a 10 mL double neck round bottom flask, 
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equipped with a stirring bar and a septum. The reaction mixture was left stirring at room 
temperature under oxygen atmosphere. After 24 h, it was transferred into a 2 mL cup and 
200 μL of the EDTA stock solution was added. The solution was left rotating for 3 h at room 
temperature. Subsequently, a microextraction was performed using n-heptane (3x500 μL). 
The sample was homogenized by vortexing carefully and the organic phase was removed. 
LC-MS analysis showed a protein mass corresponding to the mass of product 4-OT R61C-6. 
ESI-MS spectrum: mass expected 7029, mass found 7030 
 
1.3.4 Coupling of 4-(methoxycarbonyl)phenylboronic acid to protein bound terminal 
alkene 4-OT R61C-1 
 
A stock solution was prepared by dissolving 4-(methoxycarbonyl)phenylboronic acid (5.8 mg, 
32 μmol) in Na2HPO4
.2H2O buffer (400 μL, pH 7.0, 0.5 M) and DMF (400 μL). The final 
concentration in 4-(methoxycarbonyl)phenylboronic acid was 40 mM. 
210 μL of the solution of protein 4-OT R61C-1 (20 nmol), 50 μL of the 4-
(methoxycarbonyl)phenylboronic acid stock solution (2.0 μmol) and 50 μL of the catalyst 
stock solution (400 nmol in Pd, 550 nmol in BIAN) were added in a 10 mL double neck round 
bottom flask, equipped with a stirring bar and a septum. The reaction mixture was left 
stirring at room temperature under an oxygen atmosphere. After 24 h, it was transferred 
into a 2 mL cup and 200 μL of the EDTA stock solution was added. The solution was left 
rotating for 3 h at room temperature. A microextraction was then performed using n-
heptane (3x500 μL). The sample was homogenized by vortexing carefully and the organic 
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phase was removed. LC-MS analysis showed a protein mass corresponding to the mass of 
product 4-OT R61C-7 but also a peak with mass corresponding to protein 4-OT R61C-1. 
ESI-MS spectrum: mass expected 7057, mass found 7058  
 
1.3.5 Coupling of 3-(dansylamino)phenylboronic acid to protein bound terminal alkene 4-
OT R61C-1 
 
A stock solution of the fluorophore was prepared by dissolving 3-
(dansylamino)phenylboronic acid (3.7 mg, 10 μmol) in Na2HPO4
.2H2O buffer (125 μL, pH 7.0, 
0.5 M) and DMF (125 μL) . The final concentration in fluorophore was 40 mM. 
210 μL of the solution of protein 4-OT R61C-1 (20 nmol), 50 μL of the fluorophore stock 
solution (2.0 μmol) and 50 μL of the catalyst stock solution (400 nmol in Pd, 550 nmol in 
BIAN) were added in a 10 mL double neck round bottom flask, equipped with a stirring bar 
and a septum. The reaction mixture was left stirring at room temperature under oxygen 
atmosphere. After 24 h, it was transferred into a 2 mL cup and 200 μL of the EDTA stock 
solution was added. The solution was left rotating for 3 h at room temperature. DMF (1.0 
mL) was added and the mixture was centrifuged at 13300 rpm for 5 min. The supernatant 
was removed and the pellet was redissolved in deionized H2O (400 μL). LC-MS analysis 






Fluorescence imaging of SDS PAGE 
5 μg of 4-OT R61C, 6 μL or 9 μL of 4-OT R61C-8 all mixed with 10 μL of the sample buffer and 
5 μL of the ladder were loaded on SDS-PAGE (12% crosslinking). Bromophenol blue was 
excluded from the protein sample buffer because it quenches the fluorescence of the Dansyl 
fluorophore. Following the running of the gel for 50 min at 150 V, a picture was taken under 
UV light (exposure time 4 sec). The gel was then stained with Coomassie and a new picture 
was taken under visible light. 
ESI-MS spectrum: mass expected 7247, mass found 7248 
 
1.3.6 Coupling of phenylboronic acid to protein bound cis internal alkene 4-OT R61C-2 
The stock solutions of the catalyst, EDTA and phenylboronic acid were prepared as described 
previously. 
 
210 μL of the solution of protein 4-OT R61C-2 (20 nmol), 50 μL of the phenylboronic acid 
stock solution (2.0 μmol) and 50 μL of the catalyst stock solution (400 nmol in Pd, 550 nmol 
in BIAN) were added in a 10 mL double neck round bottom flask, equipped with a magnetic 
stirring bar and a septum. The reaction mixture was left stirring at room temperature under 
oxygen atmosphere. After 24 h, it was transferred into a 2 mL cup and 200 μL of the EDTA 
stock solution was added. The solution was left rotating for 3 h at room temperature. A 
microextraction was then performed using n-heptane (3x500 μL). Each time the sample was 
homogenized by vortexing carefully and the organic phase was removed. LC-MS analysis 
showed substantial conversion of the protein 4-OT R61C-2 to protein 4-OT R61C-9. 
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ESI-MS spectrum: mass expected 7014, mass found 7014  
 
1.3.7 Coupling of phenylboronic acid to protein bound trans-internal alkene 4-OT R61C-4 
 
210 μL of the solution of protein 4-OT R61C-3 (20 nmol), 50 μL of the phenylboronic acid 
stock solution (2.0 μmol) and 50 μL of the catalyst stock solution (400 nmol in Pd, 550 nmol 
in BIAN) were added in a 10 mL double neck round bottom flask, equipped with a magnetic 
stirring bar and a septum. The reaction mixture was left stirring at room temperature under 
oxygen atmosphere. After 24 h, it was transferred into a 2 mL cup and 200 μL of the EDTA 
stock solution was added. The solution was left rotating for 3 h at room temperature. A 
microextraction was then performed using n-heptane (3x500 μL). Each time the sample was 
homogenized by vortexing carefully and the organic phase was removed. LC-MS analysis 
showed very limited conversion of the protein 4-OT R61C-3 to protein 4-OT R61C-10. 




1.3.8 Coupling of 3-(dansylamino)phenylboronic acid to protein bound terminal alkene 4-
OT R61C-1 in the presence of cell lysates 
Preparation of cell lysates 
RAW 264.7 cells were cultured in DMEM supplemented with 10% FBS and 100 U/mL 
penicillin/streptomycin, and maintained at 37 oC and 5 % CO2. Cells were collected by 
scrapping, and washed with 1x PBS. Then, they were transferred into a 1.5 mL cup and 
centrifuged at 1000 rpm for 5 min at room temperature. The supernatant was removed and 
the pellet was dissolved in 1 mL lysis buffer (1980 μL of 0.5 % triton in PBS and 20 μL of 
Protease Inhibitor Cocktail (Sigma Aldrich). The solution was sonicated three times for 3 sec 
and centrifuged at 5000 rpm and 4 oC for 5 min. The supernatant, containing the cell lysates, 
was transferred into a plastic tube of 5 mL. To the protein sample were added 2 % SDS (360 
μL), ammonium bicarbonate buffer (3.25 mL, pH 8.0, 200 mM) and TCEP (360 μL, pH 8.0, 200 
mM). The sample was then incubated at 55 oC for 1h. 
Under the conditions of the oxidative Heck reaction, we observed no ligation to cysteine 
residues in cell lysate proteins and 4-OT R61C (see Control reactions below). Blocking with 
iodoacetamide was performed as a standard procedure to prevent the formation of disulfide 
bonds. 
Blocking with iodoacetamide 
Immediately before use, 25 mg of iodoacetamide were dissolved in ammonium bicarbonate 
buffer (360 μL, pH 8.0, 200 mM) to make a stock solution of a concentration of 375 mM 
(protect from light). 360 μL of this stock was added and the cell lysate sample, which was 
subsequently incubated for 30 min (protected from light). The sample was then loaded into 
a viva spin column (5000 Da cut) and centrifuged at 4000 rpm for 45 min at 4 oC. After the 
addition of ammonium formate buffer (15 mL, pH 7.0, 1 M), it was centrifuged again for 1 h 
and transferred into a 2 mL cup. The cell lysates were diluted to 6 mg/mL protein 




Fluorescent labeling of 4-OT R61C-1 in presence of cell lysates (protein ratio 1:1) 
210 μL of the solution of protein 4-OT R61C-1 (20 nmol, 138 μg), 23 μL of the cell lysates 
(138 μg), 50 μL of the fluorophore stock solution (2.0 μmol, see p.S11) and 50 μL of the 
catalyst stock solution (400 nmol in Pd, 550 nmol in BIAN) were added in a 10 mL double 
neck round bottom flask, equipped with a stirring bar and a septum. A control reaction on 
the cell lysate in absence of 4-OT R61C-1 was also set up. The reaction mixture was left 
stirring at room temperature under oxygen atmosphere. After 24 h, it was transferred into a 
2 mL cup and 200 μL of the EDTA stock solution was added and the solution was left rotating 
for 3 h at room temperature. DMF (1.0 mL) was added and the suspension was centrifuged 
at 13300 rpm for 5 min. The supernatant was removed and the pellet was redissolved in 
deionized H2O (400 μL). 30 μL of the reaction mixture was mixed with 30 μL of the sample 
buffer (without bromophenol blue) and 20 μL of this mixture were loaded three times on a 
SDS PAGE (12 %) along with 5 μL of the protein ladder. Electrophoresis was performed for 50 
min at 150 V.  
Preparation of the sample for MS 
The 4-OT bands were cut out of the SDS-PAGE, chopped in small pieces and put in a 2 mL 
cup containing 50 μL of deionized water and left overnight at 4 oC in order to let the protein 
diffuse out of the gel. Subsequently, the sample was centrifuged at 13300 rpm for 10 min at 
4 oC and the supernatant was subjected to LC-MS analysis. The analysis showed more than 
90% conversion of 4-OT R61C-1 to 4-OT R61C-8. 
ESI-MS spectrum: mass expected 7247, mass found 7248 
 
Fluorescence imaging of SDS PAGE 
5 μL of the protein ladder, 12 μL of the reaction mixture of 4-OT R61C-1 in presence of cell 
lysate mixed with 8 μL of the sample buffer and 12 μL of the blank reaction on cell lysate 
mixed with 8 μL of the sample buffer were loaded on the gel (12%). Bromophenol blue was 
excluded from the protein sample buffer because it quenches the fluorescence of the Dansyl 
fluorophore.  Following the running of the gel for 50 min at 150 V, a picture was taken under 
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UV light (exposure time 4 sec). The gel was then stained with Coomassie and a new picture 
was taken under visible light. 
Fluorescent labeling of 4-OT R61C-1 in presence of cell lysates (protein ratio 1:10) 
21 μL of the solution of protein 4-OT R61C-1 (2 nmol, 13.8 μg), 23 μL of the cell lysates (138 
μg protein content), 5 μL of the fluorophore stock solution (200 nmol) and 5 μL of the 
catalyst stock solution (40 nmol in Pd, 55 nmol in BIAN) were added in a 10 mL double neck 
round bottom flask, equipped with a stirring bar and a septum along with 200 μL ammonium 
formate buffer (pH 7.0, 50 mM). A blank reaction on the cell lysate in absence of 4-OT R61C-
1 was also set up. The reaction mixture was left stirring at room temperature under oxygen 
atmosphere. After 24 h, it was transferred into a 2 mL cup and 20 μL of the EDTA stock 
solution was added. The solution was left rotating for 3 h at room temperature. DMF (1.0 
mL) was added and the mixture was centrifuged at 13300 rpm for 5 min. The supernatant 
was removed and the pellet was redissolved in deionized H2O (200 μL). 
In order to estimate the conversion of the protein-bound alkene 4-OT R61C-1 to the product 
4-OT R61C-8, we coupled the fluorescently labeled maleimide directly to 4-OT R61C 
monomer and used the product 4-OT R61C-11 as a reference sample. 
Coupling of N-[2-(Dansylamino)ethyl]maleimide to 4-OT R61C (Michael addition)  
The reduction of the dimer was done according to the procedure described above. A stock 
solution of N-[2-(Dansylamino)ethyl]maleimide was prepared by dissolving the maleimide 
(11 mg, 0.03 mmol) in MeOH (43 μL). 30 μL of the stock solution was added to the protein 
solution and the mixture was shaken at room temperature for 10 min. The purification of 
the protein and the concentration assessment were done as described for 4-OT R61C-1. A 
solution containing 0.4 mg/mL was prepared in ammonium formate buffer (pH 7.0, 50 mM). 
An aliquot of this protein sample was directly analyzed by ESI-MS. Mass spectrometry 
revealed a protein peak with mass corresponding to the mass of 4-OT R61C-11.  
ESI-MS spectrum: mass expected 7130, mass found 7132 (7263: modified enzyme with 





Fluorescence imaging of SDS PAGE 
5 μL of the protein ladder, 6 μL of the reaction mixture of 4-OT R61C-1 in presence of cell 
lysate mixed with 10 μL of the sample buffer, 6 μL of the blank reaction on cell lysate mixed 
with 10 μL of the sample buffer and 1 μL of 4-OT R61C-11 mixed with 10 μL of the sample 
buffer were loaded on the gel (12%).  Bromophenol blue was excluded from the protein 
sample buffer because it quenches the fluorescence of the Dansyl fluorophore. Following 
the running of the gel for 50 min at 150 V, a picture was taken under UV light (exposure time 





1.4 Control reactions 
1.4.1 Control reaction 1; Oxidative Heck in absence of catalyst 
 
210 μL of the protein solution of 4-OT R61C-1 (20 nmol), 50 μL of the phenylboronic acid 
stock solution (2.0 μmol) were added sequentially in a 10 mL double neck round bottom 
flask, equipped with a stirring bar and a septum. The reaction mixture was left stirring at 
room temperature under oxygen atmosphere. After 24h, it was analyzed directly by LC-MS. 
The protein mass found to correspond to the unreacted 4-OT R61C-1. 
ESI-MS spectrum: mass expected 6923, mass found 6923 
 
1.4.2 Control reaction 2; Oxidative Heck in absence of boronic acid 
 
210 μL of the solution of protein 4-OT R61C-1 (20 nmol) and 50 μL of the catalyst stock 
solution (400 nmol in Pd, 550 nmol in BIAN) were added in a 10 mL double neck round 
bottom flask, equipped with a stirring bar and a septum. The reaction mixture was left 
stirring at room temperature under an oxygen atmosphere. After 24h, it was transferred 
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into a 2 mL cup and 200 μL of the EDTA stock solution was added. The solution was left 
rotating for 3h at room temperature. A microextraction was then performed using n-
heptane (3x500 μL). The sample was homogenized by vortexing carefully and the organic 
phase was removed. LC-MS of the aqueous phase showed a protein mass corresponding to 
the unreacted 4-OT R61C-1. 
ESI-MS spectrum: mass expected 6923, mass found 6924 
 
1.4.3 Control reaction 3; Oxidative Heck in absence of alkene 
 
210 μL of the solution of protein 4-OT R61C-4 (20 nmol), 50 μL of the 4-
methoxyphenylboronic acid stock solution (2.0 μmol) and 50 μL of the catalyst stock solution 
(400 nmol in Pd, 550 nmol in BIAN) were added in a 10 mL double neck round bottom flask, 
equipped with a stirring bar and a septum. The reaction mixture was left stirring at room 
temperature under oxygen atmosphere. After 24h, it was transferred into a 2 mL cup and 
200 μL of the EDTA stock solution was added. The solution was left rotating for 3h at room 
temperature. A microextraction was then performed using n-heptane (3x500 μL). The 
sample was homogenized by vortexing carefully and the organic phase was removed. LC-MS 
analysis of the aqueous phase showed a protein mass corresponding to the mass of the 
unreacted 4-OT R61C-4. 




1.4.4 Control reaction 4; Coupling of cysteine thiols to 3-(dansylamino)phenylboronic acid 
using the optimized conditions of the oxidative Heck reaction as a possible side reaction 
Coupling of 4-OT R61C 
 
The reduction of 4-OT R61C dimer was performed as described before. 51 μL of  the protein 
solution of reduced 4-OT R61C (20 nmol), 50 μL of the fluorophore stock solution (2.0 μmol) 
and 50 μL of the catalyst stock solution (400 nmol in Pd, 550 nmol in BIAN) were added in a 
10 mL double neck round bottom flask, equipped with a stirring bar and a septum. The 
reaction mixture was left stirring at room temperature under oxygen atmosphere. After 24 
h, it was transferred into a 2 mL cup and 200 μL of the EDTA stock solution was added. The 
solution was left rotating for 3 h at room temperature. DMF (1.0 mL) was added and the 
mixture was centrifuged at 13300 rpm for 5 min. The supernatant was removed and the 
pellet was redissolved in deionized H2O (400 μL). LC-MS analysis showed a protein mass 
corresponding to the mass of the unreacted 4-OT R61C. 




Coupling of the cysteine residues of a cell lysate in presence (ratio 1:10) and in absence of 
4-OT R61C-1 
The preparation of the cell lysate was done as described above, without treatment with 
iodoacetamide. The procedure followed for the coupling of the fluorescent 3-
(dansylamino)phenylboronic acid in presence and absence of the protein-bound alkene 4-OT 
R61C-1 was the same as described before.  
Fluorescence imaging of SDS PAGE 
5 μL of the protein ladder, 9 μL of the reaction mixture of 4-OT R61C-1 in presence of cell 
lysate mixed with 10 μL of the sample buffer and 9 μL of the blank reaction on cell lysate 
mixed with 10 μL of the sample buffer were loaded on the gel (12%).  Bromophenol blue was 
excluded from the protein sample buffer because it quenches the fluorescence of the Dansyl 
fluorophore. Following the running of the gel for 50 min at 150 V, a picture was taken under 
UV light (exposure time 4 sec). The gel was then stained with Coomassie and a new picture 
was taken under visible light.  
  
Figure S1: A)Fluorescence imaging on SDS-PAGE of 4-OT R61C-1 labeled in presence of a cell 
lysate (protein ratio 1:10). B) Coomassie staining of A. 1) the reaction in presence of 4-OT 
R61C-1 and 2) in absence of 4-OT R61C-1.  
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2. Oxidative Heck reaction on small molecules 
2.1 Materials and Methods 
Chemicals were obtained from commercial suppliers (Sigma Aldrich, Acros Organics) and 
used without further purification. Aluminum sheets of Silica Gel 60 F254 were used for Thin 
layer chromatography (TLC). Spots were visualized under ultraviolet light or stained with 
KMnO4 solution. MP Ecochrom Silica Gel 32-63 60 Å was used for column chromatography. 
Nuclear magnetic resonance spectra were recorded on a Bruker Avance 500 spectrometer 
(1H NMR (500 MHz), 13C NMR (125 MHz)). Chemical shift values are reported in ppm (δ) 
relative to tetramethylsilane (TMS). Coupling constants (J) are reported in Hz with the 
following splitting abbreviations: s = singlet, d = doublet, t = triplet, q = quartet and m = 
multiplet. GC-MS spectra were recorded on a GCMS-QP5000 Gas Chromatograph Mass 
Spectrometer. HP-5MS was used as a column. The temperature was set at 250.00 °C, the 
column inlet pressure was 92.3 kPa and the column flow was 1.5 mL/min. 
2.2 Synthesis of starting materials 
2.2.1 Synthesis of Bis(aryl)acenaphthequinonediimine (BIAN) 
BIAN was synthesized according to literature procedures.[6] 
TLC: Rf = 0.5 (5:1 pentane/ether) 
1H NMR (500 MHz, CDCl3) : δ = 7,89 (d, J = 8,3 Hz, 2H), 7,39 (t, J = 7,7 Hz, 2H), 7,08 (t, J = 7,5 
Hz, 2H), 7,16 (d, J = 7,5 Hz, 4H), 6,72 (d, J = 7,2 Hz, 2H), 2,14 (s, 12H) ppm. 13C NMR (125 
MHz, CDCl3): δ = 161.0, 149.4, 140.8, 131.2, 129.7, 129.1, 128.5, 128.4, 125.0, 123.8, 122.7, 
17.9 ppm. 
LC-MS: m/z 389.29. 
2.2.2 Synthesis of 1-(pent-4-en-1-yl)-1H-pyrrole-2,5-dione (1) (Mitsunobu reaction)  
 
In a 10 mL round bottom flask equipped with a magnetic stirring bar, the maleimide (97 mg, 
1.0 mmol) and PPh3 (0.26 g, 1.0 mmol) were dissolved in dry THF (2.0 mL). Pent-4-en-1-ol 
(0.10 ml, 1.0 mmol) and diisopropylazodicarboxylate (DIAD) (0.20 mL, 1.0 mmol) were 
added, the flask was equipped with a condenser and the mixture was left stirring for 24h 
under reflux. The solvent was evaporated under reduced pressure and the residue was 
purified by column chromatography (EtOAc/ heptane 1:10) to afford the product as a 
yellowish oil (0.13 g, 78%). 
TLC: Rf = 0.11 (EtOAc/ heptane 1:10). 
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1H NMR (500 MHz, CDCl3): δ = 6.58 (s, 2H), 5.62 (m, 1H), 4.85-4.90 (m, 1H), 4.80-4.83 (m, 
1H), 3.37 (t, J = 7.2 Hz, 2H), 1.90 (m, 2H), 1.52 (m, 2H) ppm. 13C NMR (125 MHz, CDCl3): δ= 
179.0, 136.2, 133.0, 114.2, 35.7, 29.2, 25.9 ppm. 
GC-MS: m/z 165.0. 
2.2.3 Synthesis of (Z)-1-(hex-4-en-1-yl)-1H-pyrrole-2,5-dione (2) 
 
In a 10 mL round bottom flask equipped with a magnetic stirring bar, the maleimide (97 mg, 
1.0 mmol) and PPh3 (0.26 g, 1.0 mmol) were dissolved in dry THF (2.0 mL). Cis-4-hexen-1-ol 
(0.12 ml, 1.0 mmol) and diisopropylazodicarboxylate (DIAD) (0.20 mL, 1.0 mmol) were added 
subsequently, the flask was equipped with a condenser and the mixture was left stirring for 
24h under reflux. The solvent was evaporated under reduced pressure and the residue was 
purified by column chromatography (EtOAc/ heptane 1:10) to afford the product as a 
yellowish oil (0.14 g, 78%). 
TLC: Rf = 0.5 (EtOAc/ heptane 1:1). 
1H NMR (500 MHz, CDCl3): δ = 6.62 (s, 2H), 5.40-5.34 (m, 1H), 5.28-5.23 (m, 1H), 4.80-4.83 
(m, 1H), 3.37 (t, J = 7.2 Hz, 2H), 1.90 (m, 2H), 1.52 (m, 2H) ppm.13C NMR (125 MHz, CDCl3): δ= 
170.7, 134.0, 128.9, 124.8, 37.5, 28.2, 24.1, 12.7 ppm. 
GC-MS: m/z 179.1. 
2.2.4 Synthesis of (E)-1-(hex-4-en-1-yl)-1H-pyrrole-2,5-dione (3) 
 
In a 10 mL round bottom flask equipped with a magnetic stirring bar, the maleimide (97 mg, 
1.0 mmol) and PPh3 (0.26 g, 1.0 mmol) were dissolved in dry THF (2.0 mL). Trans-4-hexen-1-ol 
(0.12 ml, 1.0 mmol) and diisopropylazodicarboxylate (DIAD) (0.20 mL, 1.0 mmol) were added, 
the flask was equipped with a condenser and the mixture was left stirring for 24h under 
reflux. The solvent was evaporated under reduced pressure and the residue was purified by 
column chromatography (EtOAc/ heptane 1:10) to afford the product as a yellowish oil (0.13 
g, 76%). 
TLC: Rf = 0.5 (EtOAc/ heptane 1:1). 
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1H NMR (500 MHz, CDCl3): δ = 6.52 (s, 2H), 5.22-5.11 (m, 2H), 3.25 (t, J = 7.4 Hz, 2H), 1.72 (m, 
2H), 1.38 (m, 2H), 1.38 (d, J = 5.9 Hz, 3H) ppm. 13C NMR (125 MHz, CDCl3): δ= 170.3, 133.7, 
129.4, 125.2, 36.9, 29.3, 27.7, 17.4 ppm. 
GC-MS: m/z 179.1. 
2.2.5 Synthesis of 1-(pent-4-en-1-yl)-3-(propylthio)pyrrolidine-2,5-dione (4) (Michael 
addition)  
 
In a 10 mL round bottom flask equipped with a magnetic stirring bar were added 
sequentially a solution of 1-(pent-4-en-1-yl)-1H-pyrrole-2,5-dione (0.17 g, 1.0 mmol) in 2.0 
mL CH3CN, 1-propanethiol (90 μL, 1.0 mmol) and triethylamine (60 μL, 0.40 mmol) and the 
mixture was left stirring at room temperature for 2h. The solvent was then evaporated and 
the residue was dissolved in ethyl acetate (3.0 mL). The organic phase was washed 3 times 
with 10 mL of NaOH 1N, dried over MgSO4 and evaporated under reduced pressure to afford 
the product 6 as a yellow oil (0.17 g, 69%). 
TLC: Rf = 0.11 (EtOAc/ heptane 1:10). 
1H NMR (500 MHz, CDCl3): δ = 5.79 (m, 1H), 4.97-5.06 (m, 2H), 3.68 (dd, J = 9 Hz, J = 3.7 Hz, 
1H), 3.52 (t, J =7.4 Hz, 2H), 3.09 (dd, J = 18.7 Hz, J = 9 Hz, 1H), 2.87 (m, 1H), 2.72 (m, 1H), 2.52 
(dd, J = 18.7 Hz, J = 3.7 Hz, 1H), 2.06 (m, 2H), 1.68 (m, 4H), 1.01 (t, J = 7.4 Hz, 3H) ppm. 13C 
NMR (125 MHz, CDCl3): δ = 176.0, 174.1, 136.3, 114.4, 37.5, 37.1, 34.6, 32.2, 29.3, 25.0, 
20.8, 11.7 ppm. 
GC-MS: m/z 241.1. 
2.3 General procedure for the oxidative Heck reaction 
The general procedure for the oxidative Heck reaction was performed as reported previously 
by Minnaard et al. with some modifications.[6]  
To a 10 mL double neck round bottom flask equipped with a magnetic stirring bar and a 
septum was added palladium acetate (11 mg, 5.0 mol %, 0.05 equiv.), and BIAN (28 mg,  7.0 
mol %, 0.07 equiv.) and the mixture was dissolved in DMF (2.0 mL) (99+%, extra pure, Acros 
Organics). The flask was equipped with an oxygen balloon on the side arm and immediately 
after the addition of DMF, oxygen was flushed through the flask and the mixture was stirred 
for 30 min at room temperature. The olefin (1.0 equiv.) and the phenylboronic acid (1.5 
equiv.) were then added to the flask and the reaction mixture was allowed to stir at room 
temperature under oxygen atmosphere. After 30h, the reaction mixture was diluted with 
ethyl acetate (5.0 mL) and washed with H2O (5x20 mL). The organic phase was dried over 
MgSO4, filtered, and the solvent was evaporated under reduced pressure. The residue was 
purified by flash column chromatography. 
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Note: The ratio of the isomers formed was estimated from the integration of the olefinic 
peaks of each isomeric product that could be distinguished in the 1H NMR spectrum.  
2.3.1 Synthesis of (E)-5-phenylpent-4-en-1-ol (5a), 4-phenylpent-3-en-1-ol (5b) and 4-
phenylpent-4-en-1-ol (5c)  
 
The title compounds were prepared from pent-4-en-1-ol (0.10 mL, 1.0 mmol) and 
phenylboronic acid (0.18 g, 1.5 mmol) according to general procedures A and B. The residue 
was purified by flash column chromatography (EtOAc/ heptane 1:20) to afford 5a, 5b and 5c 
as a mixture of isomers (yellowish solid).  
Procedure A: 109 mg, 67%. Ratio of the isomers: 5a : 5b : 5c  4.5 : 1.1 : 1. 
TLC: Rf = 0.10 (EtOAc/ heptane 1:5). 
5a: 1H NMR (500 MHz, CDCl3): δ = 7.18-7.42 (m, 5H), 6.40 (d, J = 15.7 Hz, 1H), 6.23 (m, 1H), 
3.70 (t, J = 6.4 Hz, 2H), 2.31 (m, 2H), 1.75 (m, 2H) ppm. 13C NMR (125 MHz, CDCl3): δ = 137.8, 
130.2, 128.6, 127.1, 126.3, 126.1, 62.6, 3a2.4, 29.5 ppm.   
5b: 1H NMR (500 MHz, CDCl3): δ = 7.18-7.42 (m, 5H), 5.78 (m, 1H), 3.66 (t, J = 6.4 Hz, 2H), 
2.51 (m, 2H), 2.07 (s, 3H) ppm. 13C NMR (125 MHz, CDCl3): δ = 143.7, 133.4, 128.3, 127.0, 
125.8, 123.9, 62.5, 31.3, 16.2 ppm.  
5c: 1H NMR (500 MHz, CDCl3): δ = 7,18-7,42 (m, 5H), 5,29 (s, 1H), 5,09 (s, 1H), 3,75 (t, J = 6,4 
Hz, 2H), 2,61 (t, J = 7,5 Hz, 2H), 1,73 (m, 2H).  13C NMR (125 MHz, CDCl3): δ = 148.1, 137.9, 
130.5, 128.6, 127.6, 112.7, 62.6, 32.5, 31.7 ppm. 
GC-MS: m/z 162.2. 
2.3.2 Synthesis of (E)-5-(4-methoxyphenyl)pent-4-en-1-ol (6a), 4-(4-methoxyphenyl)pent-
3-en-1-ol (6b), 4-(4-methoxyphenyl)pent-4-en-1-ol (6c) 
 
The title compounds were prepared from pent-4-en-1-ol (0.10 mL, 1.0 mmol) and 4-
methoxyphenylboronic acid (0.23 g, 1.5 mmol) according to general procedure A. The 
residue was purified by flash column chromatography (EtOAc/ heptane 1:20) to afford 6a, 6b 
and 6c as a mixture of isomers (yellowish solid).  
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Procedure A: 125 mg, 64 %. Ratio of the isomers: 6a : 6b : 6c  2.6 : 2 : 1. 
TLC: Rf = 0.10 (EtOAc/ heptane 1:5). 
6a: 1H NMR (500 MHz, CDCl3): δ = 7.26 (d, J = 8.8 Hz, 2H), 6.85 (d, J = 8.8 Hz, 2H), 6.35 (d, J = 
15.7 Hz, 1H), 6.10 (m, 1H), 3.80 (s, 3H), 3.71 (t, J = 6.4 Hz, 2.30 (m, 2H), 1.74 (m, 2H) ppm. 13C 
NMR (125 MHz, CDCl3): δ = 159.4, 130.9, 128.3, 127.5, 126.3, 114.3, 62.5, 55.3, 32.3, 29.6 
ppm.  
6b: 1H NMR (500 MHz, CDCl3): δ = 7.32 (d, J = 8.8 Hz, 2H), 6.85 (d, J = 8.8 Hz, 2H), 5.71 (m, 
1H), 3.81 (s, 3H), 3.74 (t, J = 6.5 Hz, 2H), 2.49 (m, 2H), 2.05 (s, 3H) ppm. 13C NMR (125 MHz, 
CDCl3): δ = 159.4, 130.9, 129.8, 127.1, 126.3, 113.8, 67.5, 55.3, 39.4, 29.2 ppm. 
6c: 1H NMR (500 MHz, CDCl3): δ = 7.35 (d, J = 8.8 Hz, 2H), 6.86 (d, J = 8.8 Hz, 2H), 5.23 (s, 1H), 
5.01 (s, 1H), 3.81 (s, 3H), 3.67 (t, J = 6.6 Hz, 2H), 2.58 (t, J = 7.4 Hz, 2H), 1.74 (m, 2H) ppm. 13C 
NMR (125 MHz, CDCl3): δ = 158.7, 140.8, 129.8, 127.5, 114.3, 113.8, 62.5, 55.3, 29.6, 25.6 
ppm.  
GC-MS: m/z 192. 
2.3.3 Synthesis of (E)-1-(5-phenylpent-4-en-1-yl)-3-(propylthio)pyrrolidine-2,5-dione (7a), 
1-(4-phenylpent-4-en-1-yl)-3-(propylthio)pyrrolidine-2,5-dione (7b) 
 
The title compounds were prepared from compound 7 (0.24 g, 1.0 mmol) according to 
general procedure A. However, for this reaction the amount of the catalyst (palladium 
acetate 0.23 g, 1.0 equiv), the ligand (BIAN 0.55 g, 1.4 equiv.) and phenylboronic acid (1.2 g, 
10 mmol) were increased in order to imitate the condition applied for the protein 
conjugation. After 24h, DMF was removed by extractions with H2O and the residue was 
purified by flash column chromatography (EtOAc/ heptane 1:10) to afford 7a and 7b in a 
ratio 2.3 : 1 as a yellowish oil (0.26 g, 82%). 
TLC: Rf = 0.11 (EtOAc/ heptane 1:10). 
7a: 1H NMR (500 MHz, CDCl3): δ = 7.12-7.32 (m, 5H), 6.32 (d, J = 15.8 Hz, 1H), 6.13 (m, 1H), 
3.59 (dd, J = 9 Hz, J = 3.7 Hz, 1H), 3.51 (t, J = 7.4 Hz, 2H), 3.00 (dd, J = 18.7 Hz, J = 9.0, 1H), 
2.79 (m, 1H), 2.66 (m, 1H), 2.45 (dd, J = 18.7 Hz, J = 3.7 Hz, 1H), 2.17 (m, 2H), 1.53-1.63 (m, 
4H), 0.95 (t, J = 7.4 Hz, 3H) ppm. 13C NMR (125 MHz, CDCl3): δ = 176.8, 175.0, 137.6, 130.9, 
129.2, 128.6, 127.2, 126.1, 39.1, 28.8, 36.3, 33.9, 30.4, 27.1, 22.5, 13.5 ppm. 
7b: 1H NMR (500 MHz, CDCl3): δ = 7.12-7.32 (m, 5H),  5.23 (s, 1H), 5.02 (s, 1H), 3.59 (dd, J = 9 
Hz, J = 3.7 Hz, 1H), 3.00 (dd, J = 18.7 Hz, J = 9 Hz, 1H), 2.79 (m, 1H), 2.66 (m, 1H), 2.45 (dd, J = 
18.7 Hz, J = 3.7 Hz, 1H), 1.72 (m, 6H), 0.95 (t, J = 7.4 Hz, 3H) ppm. 13C NMR (125 MHz, CDCl3): 
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δ = 176.8, 175.0, 147.3, 141.0, 128.5, 127.6, 126.2, 113.0, 39.1, 38.8, 38.7, 32.6, 29.8, 26.3, 
22.5, 13.5 ppm. 




3. NMR spectra 
 
Figure S2: 1H NMR spectrum (CDCl3, 500 MHz) of BIAN. 
 
 




Figure S4: 1H NMR spectrum (CDCl3, 500 MHz) of 1. 
 
 




Figure S6: 1H NMR spectrum (CDCl3, 500 MHz) of 2. 
 
 




Figure S8: 1H NMR spectrum (CDCl3, 500 MHz) of 3. 
 
 




 Figure S10: 1H NMR spectrum (CDCl3, 500 MHz) of 4. 
 
 




Figure S12: 1H NMR spectrum (CDCl3, 500 MHz) of 5a, 5b and 5c.  
 




Figure S14: 1H NMR spectrum (CDCl3, 500 MHz) of 6a, 6b and 6c.  
 
 





Figure S16: 1H NMR spectrum (CDCl3, 500 MHz) of 7a and 7b.  
 
 









Figure S18: A) Gas chromatogram of 1 (retention time in min). B) The mass spectrum (m/z) 



























Figure S19: A) Gas chromatogram of 2 (retention time in min). B) The mass 





























Figure S20: A) Gas chromatogram of 3 (retention time in min). B) The mass 





























Figure S21: A) Gas chromatogram of 4 (retention time in min). B) The mass spectrum (m/z) 



































Figure S22: A) Gas chromatogram of the isomers 5a, 5b and 5c (retention time in min), B) 
the mass spectrum (m/z) at 18.8 min, C) the mass spectrum (m/z) at 19.1 min and D) the 
mass spectrum (m/z) at 20.2 min of the isomers 5a, 5b and 5c. 
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Figure S23: A) Gas chromatogram of the isomers 6a, 6b and 6c (retention time in min), B) 
the mass spectrum (m/z) at 21.9 min, C) the mass spectrum (m/z) at 22.6 min and D) the 
mass spectrum (m/z) at 23.15 min of the isomers 6a, 6b and 6c.   
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Figure S24: A) Gas chromatogram of the isomers 7a and 7b (retention time in min), B) the 
mass spectrum (m/z) at 30.45 min and C) the mass spectrum (m/z) at 31.6 min of the 
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